Celltrion
068270.KS
#782
Rank
$25.76 B
Marketcap
$124.41
Share price
-4.30%
Change (1 day)
4.08%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $2.99

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $2.99. In 2022 the company made an earnings per share (EPS) of $2.91 a decrease over its 2021 EPS that were of $3.46.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.992.72%
2022$2.91-15.84%
2021$3.4612.77%
2020$3.0770.79%
2019$1.8015.63%
2018$1.55-33.13%
2017$2.32141.17%
2016$0.968.28%
2015$0.8911.28%
2014$0.8016.37%
2013$0.69-67.42%
2012$2.1184.22%
2011$1.1462.13%
2010$0.7180.61%
2009$0.39-559.63%
2008-$0.08503-123.16%
2007$0.37